<DOC>
	<DOC>NCT01812733</DOC>
	<brief_summary>The objective of the non-interventional study is to compare the quality of life, health care resource use and costs between the use of a combination of oxycodone and naloxone (Targiniq) versus oxycodone and laxatives for patients with severe pain, and to evaluate the cost-effectiveness of treatment with Targiniq.</brief_summary>
	<brief_title>Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Inclusion criteria: Male or nonpregnant female ≥18 years of age Malignant or nonmalignant opioid sensitive pain Must sign an informed consent form (ICF) Must have a stable daily dose of oxycodone prolonged release formulation titrated to analgesic effect (as to be assessed by clinical experts) Use of laxatives for concomitant opioidinduced constipation in an adequate dose and length of time and without sufficient effect BFI ≥30 and state a discomfort caused by the constipation at screening Ability to answer the patient questionnaires and have an estimated overall life expectancy of at least six (6) months Exclusion criteria: History of, or ongoing, abuse of alcohol and/or drugs Inability to read and understand written instructions, ICF or questionnaires Constipation not related to opioid use Unsuitable patient for other reason(s) in the opinion of the investigator Inpatients, if admission and/or discharge is expected during study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>